Title : SIK2 Promotes Cisplatin Resistance Induced by Aerobic Glycolysis in Breast Cancer Cells through PI3K/AKT/mTOR Signaling Pathway.

Pub. Date : 2020 May 27

PMID : 32458975






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 SIK2 Promotes Cisplatin Resistance Induced by Aerobic Glycolysis in Breast Cancer Cells through PI3K/AKT/mTOR Signaling Pathway. Cisplatin AKT serine/threonine kinase 1 Homo sapiens
2 SIK2 can promote cisplatin resistance caused by aerobic glycolysis of breast cancer cells through PI3K/AKT/mTOR signaling pathway, which may be a new target to improve cisplatin resistance of breast cancer cells. Cisplatin AKT serine/threonine kinase 1 Homo sapiens
3 SIK2 can promote cisplatin resistance caused by aerobic glycolysis of breast cancer cells through PI3K/AKT/mTOR signaling pathway, which may be a new target to improve cisplatin resistance of breast cancer cells. Cisplatin AKT serine/threonine kinase 1 Homo sapiens